This has been a great series! Thanks @SOCCA_CritCare for the work you are doing. Highlighting and refreshing important critical care papers. Very well done!
Rounding out this week's focus on Neuro ICU care, specifically endovascular therapy, is this publication in Lancet regarding IV ASA and heparin during endovascular stroke treatment https://t.co/Ed77yMqsfZ.
#COVID19 patients that received prolonged noninvasive respiratory support (HFNc included) before #ECLS (≥3 days) significantly less likely to be weaned from ECMO (approximately 50% reduction in liberation rate) or discharged from hospital @asaiojournal
📎 https://t.co/LLoELNbvn0
@KU_CCM Would this be a gaggle or a flock of monitors? I really just don’t know the right terminology for this…but feel like this is something I need to know now.
@ChrisBeanMD @SOCCA_CritCare is the Society of Critical Care Anesthesiologists. Their twitter account has been increasingly useful and interesting and it connects lots of others in the field. Welcome to fun!!
Boxhoorn et al in @NEJM look at whether outcomes in infected necrotizing pancreatitis management can be improved by early intervention in this mutlicenter randomized superiority trial with 104 patients.
Link: https://t.co/R8RVxLCOHw
@SOCCA_CritCare Only limited experience personally. Some of my colleagues (@uk_ccm) have more experience with its use. Seems to have a mild effect of vasopressor use, at best. Can’t see that it dramatically affects survival or organ failure.
Listen, read or RT what my colleague @md_hatton @UK_HealthCare has to say about #COVID#Intubation#ECMO @UKYneuroscience WUKY Goes 'One-On-One' With Dr. Kevin Hatton For A Sobering Look Inside UK's ICU Amid COVID | WUKY https://t.co/FTaPTtbSWJ